Search for the latest oncology news by tumour type
Using electricity to treat cancer
Electricity has formed the basis of many aspects of the modern world, from providing reliable…
Browsing: Tumour Stream
AACR 2022: Team of scientists and clinicians wins global award for transforming breast cancer treatment
A group of UK clinical and non-clinical scientists working together across different areas of cancer…
AACR 2022: Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma
Natural killer (NK) cells derived from cord blood that were activated and complexed with a…
AACR 2022: An AI model may predict elevated pancreatic cancer risk using electronic health records
An artificial intelligence (AI) model trained using sequential health information derived from electronic health records…
AACR 2022: KRAS G12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras)…
AACR 2022: AURORA study identifies molecular features tied to breast cancer tumour spread
Susana Garcia-Recio, PhD, a research associate in the lab of Charles M. Perou, PhD, at…
Researchers discover new molecular mechanism in promoting melanoma angiogenesis
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has…
AACR 2022: Lung cancer patients with a genetic variant linked to autoimmune disease may respond better to immunotherapy
A variant of the CTLA-4 gene associated with autoimmune disease was found to be more…
AACR 2022: Accounting for genetic factors that cause normal variations in PSA levels may improve the accuracy of prostate cancer detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer could be improved by accounting…
AACR 2022: Leukaemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy
Acute lymphoblastic leukaemia (ALL) cells from patients whose cancers did not respond to CD19-targeted CAR…